Markus Soeder, premier of the wealthy southeastern German state, said there were no contracts signed to produce the vaccine in Germany nor a European Union approval and added:
But even if both were there, it is inconceivable from our point of view that this project can now be realized. It is over.
Russian pharmaceutical firm R-Pharm set up a production facility in Bavaria to create regional manufacturing capacities in Germany that was expected to produce up to 8-10 million vaccine doses monthly.
Former German health minister Jens Spahn said in April that Germany was negotiating with Russia an advance purchase agreement of its Sputnik V vaccine, which is still pending approval from the European Union.
The start of production, scheduled for January 2022, did not take place.